13F filer · CIK 1586444
BLUE JAY CAPITAL MANAGEMENT, LLC
Los Angeles, CA · filing since Q4 2014 · last filing Aug 11, 2017
Reported value
$152.3M
$-4.1M vs prior
Positions
14
New / sold out
8 / 10
Added / reduced
2 / 4
Turnover
60.4%
buys $93.2M · sells $104.0M
Top-10 weight
76.8%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SEATTLE GENETICS INC | +328,430 | – | +$13.3M |
| New | BOSTON SCIENTIFIC CORP | +469,900 | – | +$11.0M |
| New | VERTEX PHARMACEUTICALS INC | +125,450 | – | +$10.8M |
| New | IRONWOOD PHARMACEUTICALS INC | +821,070 | – | +$10.7M |
| New | MOLINA HEALTHCARE INC | +205,270 | – | +$10.2M |
| New | BIOGEN INC | +40,000 | – | +$9.7M |
| New | NUVASIVE INC | +159,660 | – | +$9.5M |
| New | ALLERGAN PLC | +36,940 | – | +$8.5M |
| Added | BIOMARIN PHARMACEUTICAL INC | +77,253 | +103.0% | +$6.0M |
| Added | MASIMO CORP | +65,404 | +42.6% | +$3.4M |
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | COOPER COS INC | -92,690 | -100.0% | $-14.3M |
| Sold out | IONIS PHARMACEUTICALS INC | -318,490 | -100.0% | $-12.9M |
| Sold out | INTEGRA LIFESCIENCES HLDGS C | -180,000 | -100.0% | $-12.1M |
| Sold out | QIAGEN NV | -475,000 | -100.0% | $-10.6M |
| Sold out | ST JUDE MED INC | -190,140 | -100.0% | $-10.5M |
| Sold out | AGILENT TECHNOLOGIES INC | -250,000 | -100.0% | $-10.0M |
| Sold out | QUEST DIAGNOSTICS INC | -92,949 | -100.0% | $-6.6M |
| Sold out | PATTERSON COMPANIES INC | -142,600 | -100.0% | $-6.6M |
| Sold out | ALEXION PHARMACEUTICALS INC | -45,000 | -100.0% | $-6.3M |
| Sold out | INCYTE CORP | -85,000 | -100.0% | $-6.2M |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | NEUROCRINE BIOSCIENCES INCCOMMON STOCKS | 305,630 | $13.9M | 9.12% |
| 2 | SEATTLE GENETICS INCCOMMON STOCKS | 328,430 | $13.3M | 8.72% |
| 3 | MEAD JOHNSON NUTRITION COCOMMON STOCKS | 135,045 | $12.3M | 8.05% |
| 4 | BIOMARIN PHARMACEUTICAL INCCOMMON STOCKS | 152,253 | $11.8M | 7.78% |
| 5 | MASIMO CORPCOMMON STOCKS | 218,960 | $11.5M | 7.55% |
| 6 | ABIOMED INCCOMMON STOCKS | 104,920 | $11.5M | 7.53% |
| 7 | BOSTON SCIENTIFIC CORPCOMMON STOCKS | 469,900 | $11.0M | 7.21% |
| 8 | VERTEX PHARMACEUTICALS INCCOMMON STOCKS | 125,450 | $10.8M | 7.09% |
| 9 | IRONWOOD PHARMACEUTICALS INCCOMMON STOCKS | 821,070 | $10.7M | 7.05% |
| 10 | MOLINA HEALTHCARE INCCOMMON STOCKS | 205,270 | $10.2M | 6.73% |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.